| Literature DB >> 26431986 |
Nicola K Viebig1, Flavia D'Alessio2, Simon J Draper3, B Kim Lee Sim4, Benjamin Mordmüller5, Paul W Bowyer6, Adrian J F Luty7, Stefan Jungbluth2, Chetan E Chitnis8, Adrian V S Hill3, Peter Kremsner5, Alister G Craig9, Clemens H M Kocken10, Odile Leroy2.
Abstract
The deployment of a safe and effective malaria vaccine will be an important tool for the control of malaria and the reduction in malaria deaths. With the launch of the 2030 Malaria Vaccine Technology Roadmap, the malaria community has updated the goals and priorities for the development of such a vaccine and is now paving the way for a second phase of malaria vaccine development. During a workshop in Brussels in November 2014, hosted by the European Vaccine Initiative, key players from the European, North American and African malaria vaccine community discussed European strategies for future malaria vaccine development in the global context. The recommendations of the European malaria community should guide researchers, policy makers and funders of global health research and development in fulfilling the ambitious goals set in the updated Malaria Vaccine Technology Roadmap.Entities:
Keywords: Antigen discovery; Capacity building; Controlled human malaria infection; Correlates of protection; Malaria; Vaccine
Mesh：
Substances：
Year: 2015 PMID： 26431986 DOI： 10.1016/j.vaccine.2015.09.074
Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641